These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35129732)

  • 21. Clinical and echocardiographic outcomes after implantation of the Trifecta aortic bioprosthesis: an initial single-centre experience.
    Dell'Aquila AM; Schlarb D; Schneider SR; Sindermann JR; Hoffmeier A; Kaleschke G; Martens S; Rukosujew A
    Interact Cardiovasc Thorac Surg; 2013 Feb; 16(2):112-5. PubMed ID: 23159508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term follow up with the 3f Enable aortic bioprosthesis: clinical and echocardiographic results.
    Concistrè G; Miceli A; Marchi F; Farneti P; Chiaramonti F; Solinas M; Glauber AG
    J Heart Valve Dis; 2013 Nov; 22(6):817-23. PubMed ID: 24597403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Final 5-year outcomes following aortic valve replacement with a RESILIA™ tissue bioprosthesis.
    Bartus K; Litwinowicz R; Bilewska A; Stapor M; Bochenek M; Rozanski J; Sadowski J; Filip G; Kusmierczyk M; Kapelak B
    Eur J Cardiothorac Surg; 2021 Jan; 59(2):434-441. PubMed ID: 33141188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical performance of a novel bioprosthetic surgical aortic valve in a German high-volume center.
    El-Sayed Ahmad A; Giammarino S; Salamate S; Fehske W; Sirat S; Amer M; Bramlage P; Bakhtiary F; Doss M
    J Card Surg; 2022 Dec; 37(12):4833-4840. PubMed ID: 36403275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular mass regression after sutureless implantation of the Perceval S aortic valve bioprosthesis: preliminary results.
    Santarpino G; Pfeiffer S; Pollari F; Concistrè G; Vogt F; Fischlein T
    Interact Cardiovasc Thorac Surg; 2014 Jan; 18(1):38-42. PubMed ID: 24105865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Concerning Outcomes for the Edwards Inspiris Resilia Bioprosthesis in the Pulmonary Position.
    Said SM; Hiremath G; Aggarwal V; Bass J; Sainathan S; Salem MI; Narasimhan S
    Ann Thorac Surg; 2023 Apr; 115(4):1000-1007. PubMed ID: 36174775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Results after Aortic Valve Replacement Using Last Generation Bioprosthetic Aortic Valve.
    Useini D; Schlömicher M; Haldenwang P; Naraghi H; Moustafine V; Bechtel M; Strauch J
    Heart Surg Forum; 2021 Nov; 24(6):E598-E962. PubMed ID: 34962472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial.
    Hiremath CS; Jain AR; Garg A; Gupta N; Mishra YK; Meharwal ZS; Thakur N; Maslekar AA; Shastri N
    J Cardiothorac Surg; 2020 Jun; 15(1):140. PubMed ID: 32539847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety, efficacy, and hemodynamic performance of a stented bovine pericardial aortic valve bioprosthesis: Two-year analysis.
    Dagenais F; Moront MG; Brown WM; Reardon MJ; Chu MWA; Gearhart E; Klautz RJM
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):371-381.e4. PubMed ID: 31590957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic performance of the Edwards Prima Plus stentless valve at 1 year.
    Tanaka K; Kinoshita T; Fujinaga K; Kanemitsu S; Tanaka J; Suzuki H; Tokui T
    Gen Thorac Cardiovasc Surg; 2008 Sep; 56(9):441-5. PubMed ID: 18791668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular remodeling, hemodynamics and early clinical outcomes after aortic valve replacement with the Pericarbon Freedom stentless bioprosthesis: results from the Italian Prospective Multicenter Trial.
    D'Onofrio A; Mazzucco A; Valfrè C; Zussa C; Martinelli L; Casabona R; Mazzola A; Gherli T; Badano LP; Fabbri A
    J Heart Valve Dis; 2011 Sep; 20(5):531-9. PubMed ID: 22066357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue.
    Puskas JD; Bavaria JE; Svensson LG; Blackstone EH; Griffith B; Gammie JS; Heimansohn DA; Sadowski J; Bartus K; Johnston DR; Rozanski J; Rosengart T; Girardi LN; Klodell CT; Mumtaz MA; Takayama H; Halkos M; Starnes V; Boateng P; Timek TA; Ryan W; Omer S; Smith CR;
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):432-439. PubMed ID: 28605428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic Performance and Durability of Mosaic Bioprostheses for Aortic Valve Replacement, up to 13 Years.
    Matsumoto Y; Fujita T; Hata H; Shimahara Y; Sato S; Kobayashi J
    Circ J; 2015; 79(5):1044-51. PubMed ID: 25740500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do differences in early hemodynamic performance of current generation biologic aortic valves predict outcomes 1 year following surgery?
    Thalji NM; Suri RM; Michelena HI; Greason KL; Dearani JA; Daly RC; Joyce LD; Stulak JM; Burkhart HM; Li Z; Schaff HV
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):163-73.e2. PubMed ID: 25439772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-Year Outcomes After Bicuspid Aortic Valve Replacement With a Novel Tissue Bioprosthesis.
    Bavaria JE; Mumtaz MA; Griffith B; Svensson LG; Pibarot P; Borger MA; Thourani VH; Blackstone EH; Puskas JD
    Ann Thorac Surg; 2024 Jul; 118(1):173-179. PubMed ID: 38135262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical Experience of Aortic Valve Replacement Using the New Stentless Bioprosthesis].
    Uchida T; Hamasaki A; Kuroda Y; Nakamura K; Mizumoto M; Yamashita A; Hayashi J; Hirooka S; Ishizawa A; Akabane K; Sadahiro M
    Kyobu Geka; 2018 Nov; 71(12):983-988. PubMed ID: 30449863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The aortic Elan stentless aortic valve: excellent hemodynamics and ease of implantation.
    Flynn M; Iaccovoni A; Pathi V; Butler J; Macarthur KJ; Berg GA
    Semin Thorac Cardiovasc Surg; 2001 Oct; 13(4 Suppl 1):48-54. PubMed ID: 11805949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-year hemodynamic performance, left ventricular mass regression, and prosthetic-patient mismatch after rapid deployment aortic valve replacement in 287 patients.
    Haverich A; Wahlers TC; Borger MA; Shrestha M; Kocher AA; Walther T; Roth M; Misfeld M; Mohr FW; Kempfert J; Dohmen PM; Schmitz C; Rahmanian P; Wiedemann D; Duhay FG; Laufer G
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2854-60. PubMed ID: 25218544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
    Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
    JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stented bioprosthetic valve hemodynamics: is the supra-annular implant better than the intra-annular?
    Badano LP; Pavoni D; Musumeci S; Frassani R; Gianfagna P; Baldassi M; Tursi V; Mazzaro E; Zakja E; Fioretti PM; Livi U
    J Heart Valve Dis; 2006 Mar; 15(2):238-46. PubMed ID: 16607907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.